Shimizu, Y.; Yamanashi, H.; Miyata, J.; Takada, M.; Noguchi, Y.; Honda, Y.; Nonaka, F.; Nakamichi, S.; Nagata, Y.; Maeda, T.
VEGF Polymorphism rs3025039 and Human T-Cell Leukemia Virus 1 (HTLV-1) Infection among Older Japanese Individuals: A Cross-Sectional Study. Bioengineering 2022, 9, 527.
https://doi.org/10.3390/bioengineering9100527
AMA Style
Shimizu Y, Yamanashi H, Miyata J, Takada M, Noguchi Y, Honda Y, Nonaka F, Nakamichi S, Nagata Y, Maeda T.
VEGF Polymorphism rs3025039 and Human T-Cell Leukemia Virus 1 (HTLV-1) Infection among Older Japanese Individuals: A Cross-Sectional Study. Bioengineering. 2022; 9(10):527.
https://doi.org/10.3390/bioengineering9100527
Chicago/Turabian Style
Shimizu, Yuji, Hirotomo Yamanashi, Jun Miyata, Midori Takada, Yuko Noguchi, Yukiko Honda, Fumiaki Nonaka, Seiko Nakamichi, Yasuhiro Nagata, and Takahiro Maeda.
2022. "VEGF Polymorphism rs3025039 and Human T-Cell Leukemia Virus 1 (HTLV-1) Infection among Older Japanese Individuals: A Cross-Sectional Study" Bioengineering 9, no. 10: 527.
https://doi.org/10.3390/bioengineering9100527
APA Style
Shimizu, Y., Yamanashi, H., Miyata, J., Takada, M., Noguchi, Y., Honda, Y., Nonaka, F., Nakamichi, S., Nagata, Y., & Maeda, T.
(2022). VEGF Polymorphism rs3025039 and Human T-Cell Leukemia Virus 1 (HTLV-1) Infection among Older Japanese Individuals: A Cross-Sectional Study. Bioengineering, 9(10), 527.
https://doi.org/10.3390/bioengineering9100527
